ARCHIVES

Study Finds 4-20% Of Those With HTLV-3 Develop AIDs Within 32 Months Or Less

This article is from The Cancer Letter archive.

Vol. 11 No. 31 | August 2, 1985

Download PDF Visit The Full Archive

Related Articles

NCI’s Richard Kaplan named associate director, National Cancer Research Network of UK.

January 2, 2004

FDA Approvals: Lymphoseek Label Updated to Include Head and Neck SCC

June 27, 2014

Interview: Extramural Programs Need Coordination, Klausner Says

July 25, 1997

Medicare Expands Coverage for Lymphedema Pumps.

May 11, 2001

In Brief: USC Study Finds Sedentary Occupations Increase Colon Cancer Risk for Men Over More Active Jobs

November 30, 1984

ACS Defends Dialogue, Calls Story “Misleading”.

October 20, 2000